The role of vasoactive substances in hyperhemodynamics after orthotopic liver transplantation in cirrhotic rats

Chinese Medical Journal

Volumn 116, Issue 3, 2003, Pages 405-409

  Cao, Hui ^a   Wu, Zhiyong ^a   Zhang, Xiaojie ^a   Zhang, Haiying ^a   Chen, Zhiping ^a   Kuang, Yaolin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hemodynamics; Liver cirrhosis; Liver transplantation; Portal hypertension; Rat

Indexed keywords

CARBON TETRACHLORIDE; ENDOTHELIN; GLUCAGON; NITRIC OXIDE; PROSTAGLANDIN; RADIOACTIVE MICROSPHERE; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GLUCAGON BLOOD LEVEL; HEMODYNAMICS; INFERIOR CAVA VEIN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PORTAL HYPERTENSION; RADIOIMMUNOASSAY; RAT; SPLANCHNIC BLOOD FLOW; STATISTICAL ANALYSIS;

ANIMALS; ENDOTHELINS; EPOPROSTENOL; GLUCAGON; HEMODYNAMIC PROCESSES; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER TRANSPLANTATION; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; THROMBOXANE A2;

EID: 0037357525     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hadengue A, Lebredc D, Morear R. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology 1993;17:175-178.
2. Navasa M, Feu F, Garcia-Pagan JC, et al. Hemodynamic and humoral changes after liver transplantation in patient with cirrhosis. Hepatology 1993;17:355-360.
3. Henderson JM. Abnormal splanchnic and systemic hemodynamics of end-stage liver disease: what happens after liver transplantation? Hepatology 1993;17:514-516.
4. Cao H, Wu ZY, Zhang ZJ, et al. Changes in systemic and splanchnic hemodynamics after orthotopic liver transplantation in cirrhotic rats. Chin Med J 2000;113:1108-1111.
5. Wu ZY, Zhou J, Chen ZP, et al. The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats. Chin J Surg 1998;36:182-186.
6. Lerman A, Click RL, Narr BJ, et al. Elevation of plasma endothelin associated of systemic hypertension in humans following orthotopic liver transplantation. Transplantation 1991; 51:645-650.
7. Esteban F, Gomez-Jimenez J, Martin MC, et al. Nitric oxide and hepatic ischemic injury in human orthotopic liver transplantation. Transplantation Proceeding 1995;27:2283-2285.
8. Ioannidis I, Hellinger A, Dehmlow C, et al. Evidence for increased nitric oxide production after liver transplantation in humans. Transplantation 1995;59:1293-1297.
9. Sitzmann JV, Campbell KA, Wu Y, et al. Prostacyclin production in acute , chronic, and long-term experimental portal hypertension. Surgery 1994;115:290-294.
10. 2 and glucagon levels in humans. Ann Surg 1993;217:248-253.
11. Cao H, Wu ZY, Zhou J, et al. Mechenism of overproduction of plasma prostacycloin in portal hypertensive rats. Chin Med J 1998;111:1064-1067.
12. Cao H, Wu ZY, Zhou J, et al. Effects of nitre oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats. Chin Med J 1999;112:516-519.
13. Wu ZY, Jiao Z, Chen ZP, et al. Effects of somatostatin analog on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. Chin Exp Surg J 1997;14:10-12.
14. Zhu JY, Leng XS, Feng HQ, et al. Effects of somatostatin on portal vein, hepatic vein and portal venous pressure in cirrhotic portal hypertensive patients. Chin J Surg 1998;36:433-435.
15. Sika M, Blair KT, Jabbour K, et al. Mechinisms of hyperinsulinemia and hyperglucagonemia after liver transplantation. J Surg Res 1997;70:144-150.
16. Textor SC, Burnett JC, Romero JC, et al. Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kideney Int 1995;47:1426-1433.
17. Textor SC, Wilson DJ, Lerman A, et al. Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation. Transplantation 1992;54:74-80.